323 related articles for article (PubMed ID: 8202046)
1. Acute leukemia in association with Langerhans cell histiocytosis.
Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
[TBL] [Abstract][Full Text] [Related]
2. Association of Langerhans cell histiocytosis with malignant neoplasms.
Egeler RM; Neglia JP; Puccetti DM; Brennan CA; Nesbit ME
Cancer; 1993 Feb; 71(3):865-73. PubMed ID: 8431870
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases.
Aricò M; Comelli A; Bossi G; Raiteri E; Piombo M; Egeler RM
Med Pediatr Oncol; 1993; 21(4):271-3. PubMed ID: 8469222
[TBL] [Abstract][Full Text] [Related]
4. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society.
Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME; Nicholson HS
Hematol Oncol Clin North Am; 1998 Apr; 12(2):369-78. PubMed ID: 9561906
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis in a child while in remission for acute lymphocytic leukemia.
Chiles LR; Christian MM; McCoy DK; Hawkins HK; Yen AH; Raimer SS
J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S233-4. PubMed ID: 11712070
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
[TBL] [Abstract][Full Text] [Related]
7. Development of acute lymphoblastic leukemia in a child after treatment of Langerhans cell histiocytosis: report of one case.
Wu JH; Lu MY; Lin KH; Jou ST; Lin DT
Acta Paediatr Taiwan; 1999; 40(6):441-2. PubMed ID: 10927961
[TBL] [Abstract][Full Text] [Related]
8. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis.
Kager L; Heise A; Minkov M; Möbius D; Kotte W; Schulte-Overberg U; Henze G; Gadner H
Pediatr Hematol Oncol; 1999; 16(3):251-6. PubMed ID: 10326224
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis following childhood acute lymphoblastic leukemia.
Raj A; Bendon R; Moriarty T; Suarez C; Bertolone S
Am J Hematol; 2001 Dec; 68(4):284-6. PubMed ID: 11754419
[TBL] [Abstract][Full Text] [Related]
13. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
[TBL] [Abstract][Full Text] [Related]
14. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.
Pina-Oviedo S; Torres-Cabala CA; Miranda RN; Tetzlaff MT; Singh S; Rapini RP; Prieto VG; Aung PP
Am J Dermatopathol; 2017 May; 39(5):388-392. PubMed ID: 27759701
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.
Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
Eur J Cancer; 2022 Sep; 172():138-145. PubMed ID: 35772351
[TBL] [Abstract][Full Text] [Related]
16. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Gadner H; Heitger A; Grois N; Gatterer-Menz I; Ladisch S
Med Pediatr Oncol; 1994; 23(2):72-80. PubMed ID: 8202045
[TBL] [Abstract][Full Text] [Related]
18. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.
Hijiya N; Gaynon P; Barry E; Silverman L; Thomson B; Chu R; Cooper T; Kadota R; Rytting M; Steinherz P; Shen V; Jeha S; Abichandani R; Carroll WL
Leukemia; 2009 Dec; 23(12):2259-64. PubMed ID: 19741725
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
